Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins capable of inducing broadly reactive T- and B-cell responses

Modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins capable of inducing broadly reactive T- and B-cell responses

US Patent 9844589 · Granted Dec 19, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral pouch product2025
Hepatitis B virus vaccines2025
Methods and systems for incorporating nicotine into oral products2025
Conserved region T cell vaccines for coronavirus and methods of use2025
Inhibitors of complement factor H2025
Inhibitors of complement factor H2025
Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C viru2025
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
Multiplexed nucleic acid detection kit for human papilloma virus (HPV) typing, a2024
HIV-1 envelope stabilizing mutations2024
Conserved region T cell vaccines for coronavirus and methods of use2024
HIV-1 neutralizing antibodies and uses thereof2024